Kenneth C. Anderson, MD, and Francesca M. Gay, MD, on Newly Diagnosed Multiple Myeloma: Results From the FORTE Trial
Posted: Tuesday, August 15, 2017
Kenneth C. Anderson, MD, of Dana-Farber Cancer Institute, and Francesca M. Gay, MD, of the University of Torino, discuss interim study findings on carfilzomib-lenalidomide-dexamethasone vs carfilzomib-cyclophosphamide-dexamethasone induction in newly diagnosed disease.